Search Results

Displaying Results 1-1 of 1 "'MNMD'"
Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.
Psychedelic Biotechs Push Toward Phase 3: Five Companies Advancing CNS Treatments

Feb 27, 2026, 11:44 ET Psychedelic Biotechs Push Toward Phase 3: Five Companies Advancing CNS Treatments

initiation. Generalized anxiety disorder and major depressive disorder together affect over 50 million people in the United States. The ticker changed from MNMD to DFTX effective January 13.GH Research (NASDAQ: GHRS) in January

More news about: Equity Insider

Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.